EpigenDx’s Stem Cell Panel covers 790 CpG sites within 33 human genes, including pluripotency-associated genes, DNA methyltransferases, imprinted genes, genes involved in X-chromosome inactivation, and cell differentiation regulators.
Each assay was individually developed and validated using Pyrosequencing technology. They are tested to ensure no PCR bias, and offer quantitative CpG site specific results guaranteeing the highest quality and accuracy.